Conversely, reduced expression of eEF1A-KMT2 is correlated with decreased survival in patients with renal cell carcinoma (62), while lower expression of eEF1A-KMT3 in gastric cancer is associated with poor prognosis (61). This evidence concerns the gene EEF1A1 and gastric cancer.